SHL Plans New Pen-injector Plant in Taiwan

Taipei, Dec. 12, 2008 (CENS)--The SHL Group, the world's largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, including pen-injectors, auto-injectors and inhaler systems, recently confirmed its plan to invest to build a plant in Taiwan by the end of the year.

Roger Samuelsson, chairman of SHL, said that a new factory to be built in northern Taiwan's Taoyuan County will help to turn the island into the world's largest production base of pen-injectors, with the facility expected to create over 2,000 jobs.

SHL chairman said that all its pen-injector production lines are flooded with orders, and its capacity is expected to reach 120 million units in 2009 to become the world's largest supplier of such product in 2010.

The chairman stressed that SHL would invest at least US$100 million in Taiwan in the future.

SHL's new plant would be twice as large as the company's existing facility in Taiwan.

Samuelsson started his career in 1989 in Taiwan and turned to focus on pen injectors in 1996. With production bases in Taiwan and mainland China, SHL sells its high-quality products to all major pharmaceutical brands, including the top-10.

About 70% of SHL's revenue now comes from pen injectors, though the group has diversified into medical-bed and metal-processing medical materials etc. Industry insiders estimated that SHL's revenue would exceed NT$10 billion (US$303.03 million) in two years.